An exclusive look into the minds of TrialCard’s industry thought-leaders. Stay updated on trending topics and the latest initiatives taking place at TrialCard.
We invite you to share the following posts with your network. If you have a topic you’d like us to address, please let us know! Email firstname.lastname@example.org.
Last week, the Centers for Medicare and Medicaid Services (CMS) released the final 2021 Notice of Benefit and Payment Parameters (NBPP) rule. The complete rule is 350 pages and [...]
Scott Dulitz, Chief Strategy Officer at TrialCard, discusses how combining payer intelligence with market-leading technology can enhance patient access. TrialCard recently acquired Policy Reporter, a healthcare software solutions company [...]
The Situation If you're part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the [...]
Over the past few weeks, all of us have been impacted by the COVID-19 pandemic. As we continue to adjust to these changing times, I wanted to update you on [...]
The issue of co-pay card fraud has been in the news for some time, but with the increased prevalence of high-priced specialty products, the cost of missing this fraud [...]
Pharmaceutical manufacturer hub programs have, for many years, played a vital role in getting patients access to life-saving and life-altering medications. There is no question the value of these [...]
On a single day in early January 2019, TrialCard Incorporated’s Pharmacy Fraud Detection team identified and blocked three pharmacies engaged in fraudulent behavior associated with pharmaceutical co-pay programs. These [...]
The only thing that’s not rare about rare disease is the energy that the TrialCard team puts behind our 26 customers who manufacture Orphan Drugs and the patients they [...]